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Biloma is an encapsulated bile collection outside the
biliary tree due to bile leakage [1]. It has been reported
to occur as a result of all kinds of biliary injury owing to
procedures such as biliary surgery [2], cholecystec-
tomy [3,4], percutaneous biliary drainage, endoscopic
retrograde cholangiopancreatography (ERCP), trans-
catheter arterial chemoembolization (TACE), percuta-
neous ethanol injection, and radiofrequency ablation
[5]. The development of biloma after TACE is closely
related to chemoembolic agents [6]. TACE-related
biloma using microspheres has not been previously
reported. Herein, we report a 44-year-old man with
hepatocellular carcinoma who developed an intra-
hepatic biloma post embolization with microspheres
as a devascularizing agent.
CASE PRESENTATION
A 44-year-old man, a carrier of chronic hepatitis B, was
found to have a 12-cm tumor with satellite nodules 
in the anterior superior segment (S8) of the right
hepatic lobe with local intrahepatic duct invasion in
August 2004. Hepatocellular carcinoma was vali-
dated by pathologic examination. Surgical resection
was not preferred. He received TACE for major tumor
in August 2004. Another 5,000 Gy dosage of irradia-
tion was given for bile duct invasion 10 days later.
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We report a case of intrahepatic biloma following transcatheter arterial chemoembolization (TACE)
with microspheres in a 44-year-old male patient. He was diagnosed with hepatocellular carcinoma
with satellite nodules and intrahepatic duct invasion in August 2004. TACE was performed with a
mixture of lipiodol, epirubicin hydrochloride, and mitomycin followed by microspheres as devas-
cularizing material. Local external irradiation was performed on the area of intrahepatic duct
invasion after the first TACE. Owing to local tumor progression and growth of new tumor nodules,
a series of TACEs were performed. However, fever and diarrhea developed 2 weeks after the
third TACE. Biloma with infection was diagnosed and was then treated successfully with percu-
taneous drainage and antibiotics. Embolization using microspheres at the proximal right hepatic
artery was considered to have been the jeopardizing etiologic factor of biloma formation.
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The embolization agents used in the first TACE ses-
sion were a mixture of 14 mL lipiodol (Andre Guebet,
Aulany-sous-Bois, France), 8 mg mitomycin (Kyowa,
Tokyo, Japan) and 40 mg epirubicin hydrochloride
(Pfizer, Milan, Italy), followed by microspheres
(BioSphere Medical, Roissy CDG Cedex, France)
ranging in size between 100 and 300 µm (n = 4 mL) as
well as 300 and 500 µm (n = 1 mL) via the right anterior
hepatic artery. No further invasion of the intrahepatic
duct was found after the above treatment was given.
The main tumor remained the same size with 50%
lipiodol deposits at post-embolization computed
tomography (CT) evaluation, which revealed a par-
tial embolization result. Another angiography was
performed in November 2004, which showed only
minor residual tumor. TACE was again performed,
with a mixture of 3 mL lipiodol, 3 mg mitomycin and
20 mg epirubicin hydrochloride followed by micro-
spheres ranging in size between 40 and 120 µm (n =
1.4 mL) via the right anterior superior hepatic artery.
Six months later, CT revealed one new nodule at the
superior portion of the posterior segment of the right
hepatic lobe (S7) with suspicious viable tumor part.
A third TACE was performed via the right hepatic
artery, with a mixture of 4 mL lipiodol, 20 mg epiru-
bicin hydrochloride, and 4 mg mitomycin followed by
microspheres ranging in size between 100 and 300 µm
(n = 1 mL).
Two weeks after the third TACE session, the
patient’s condition became complicated with fever,
epigastric pain, and watery diarrhea. Initial labora-
tory findings showed elevated total bilirubin and C-
reactive protein. The white blood cell count had also
increased to 32,360/µL. Abdominal CT disclosed the
same findings as the previous TACE of lipiodol depo-
sition at S8 main tumor and a dense lipiodol deposit
at S6 new nodule (Figure 1A). However, a newly lobu-
lated low-density mass was also noted over the right
posterior segment (S6) of the liver just below the
dense lipiodol deposit (Figure 1B). Echo-guided per-
cutaneous drainage was performed and bilious fluid
(120 mL) along with debris was extracted. CT scan
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Figure 1. Intrahepatic biloma developed after the third chemoem-
bolization with microspheres and a mixture of anticancer drugs
and lipiodol: (A) 50% lipiodol deposits in the main tumor at the
right anterior superior segment and dense lipiodol in the S6 nod-
ule; (B) post-contrast-enhanced computed tomography shows lob-
ulated low-density biloma (arrows) in the right posterior inferior
segment; (C) percutaneous drainage of the biloma with an 8-Fr
catheter (white arrow), after which the size of the biloma markedly
decreased.
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immediately after the drainage procedure revealed
collapse of the cystic mass (Figure 1C). Culture of the
drained fluid revealed Klebsiella pneumoniae. Biloma
with infection was diagnosed. He was then treated
with intravenous cefmetazole sodium (Sankyo, Tokyo,
Japan) 1 g every 6 hours for 6 weeks, and subsequent
oral cefaclor (TBC, Taoyuan, Taiwan) 500 mg three
times daily for another 2 weeks. During the hospital-
ization period, his fever fluctuated for 3 weeks and
gradually returned to normal. His white blood cell
count slowly declined from a peak of 32,360/µL to
8,140/µL over 2 weeks. His C-reactive protein levels on
admission and 2 weeks later were 218.2 and 74.5 µg/
mL, respectively. Total bilirubin levels were 3.7 and
1.81mg/dL, respectively. Bile was drained with a daily
amount > 100 mL for 20 days, and then this decreased.
Shrinkage of the biloma was achieved 2 months later
and the catheter was eventually removed.
DISCUSSION
TACE is widely used in the treatment of hepatic
tumors. The complications of TACE include acute
hepatic failure, liver infarction or abscess, intrahepatic
biloma, multiple intrahepatic aneurysms, cholecystitis,
splenic infarction, gastrointestinal mucosal lesions,
pulmonary embolism or infarction, tumor rupture,
variceal bleeding, and iatrogenic dissection or per-
foration of the celiac artery and its branches [7].
Intrahepatic biloma is one of the major complications
that can result in severe illness such as abscess or sep-
sis [5]. Sakamoto et al reported that the incidence of
intrahepatic biloma post TACE was 0.87% (20/2,300
patients) [7]. The risk is probably high when TACE is
performed by using “small-sized” emboli. Although
the pathogenesis of biloma after chemoembolization is
not completely understood, the microvascular dam-
age of peribiliary capillary plexus which results in bile
duct necrosis and bile leakage is considered the most
likely mechanism [8–10]. Microspheresize < 60µm may
allow them to enter the peribiliary plexus and cause
microscopic injury [11]. Areas of bile duct injuries or
biloma should be closed to the area of TACE [8].
In our patient, development of intrahepatic biloma
was in the area of smaller recurrence as distinct from
the main tumor. During the previous two TACEs,
super-selective embolization was performed via the
right anterior branches. In contrast, the third TACE
was performed via the right hepatic artery in order to
cover the newly grown tumors located at the posterior
segments (Figure 2A). Owing to a decrease of the main
tumor burden, it is possible that a greater amount of
embolization agents went into the posterior branch of
the right hepatic artery, resulting in biloma developing
there. Angiography immediately after the third TACE
showed obliteration of most of the distal branch of
the right hepatic artery correlated with the develop-
ment of biloma (Figure 2B). Irradiation might con-
tribute to the development of biloma; however,
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Figure 2. Arteriography reveals some tumor stains over the right hepatic lobe. The third TACE was performed via the right hepatic
artery with a mixture of 4 mL lipiodol, 20 mg epirubicin hydrochloride, and 4 mg mitomycin followed by microspheres ranging in size
between 100 and 300mm (n = 1 mL). (A) Pre-embolization: the tumor burden (white arrow) and the distal branch of the right hepatic
artery (black arrow) were enhanced by contrast media. (B) Post-embolization: angiography shows disappearance of tumor stain (white
arrow) and obliteration of the branches of the right hepatic artery (black arrows).
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irradiation had been performed 7 months previously
and had targeted the right anterior branch of the bile
duct, which was not correlated with the position of
the biloma. Thus, it was not considered the primary
cause of the biloma in this case.
Microspheres are spherical-shaped polyvinyl alco-
hol embolic devices that provide targeted vascular
occlusion or reduction of blood flow within target
vessels. The characteristics of microspheres are lack of
aggregation, smoothness and possession of a hydro-
philic surface, all of which should result in a lower
rate of complications [12]. According to general med-
ical opinion, microspheres that range in size between
100 and 300µm are too large to obstruct the peribiliary
plexus artery, and injury to the bile duct should thus
not occur. However, in our patient, the development
of biloma was closely related to the time of emboliza-
tion that included use of microspheres. Embolization
using microspheres at the proximal right hepatic
artery was considered to have been the jeopardizing
etiologic factor of biloma formation in this patient.
In conclusion, the development of biloma might
occur with current medical procedures and techniques;
new agents that have fewer side effects or complica-
tions have yet to be developed. This case shows the
importance of a delicate approach to avoid this uncom-
mon complication, and the necessity of close observa-
tion of any patient receiving embolization using any
kind of embolization agent.
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